Swedish Orphan Biovitrum AB (publ) (BIOVF)

BIOVF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 22, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11,036	9,849	9,017	6,125	6,042	5,887
Market Cap Growth	15.82%	9.23%	47.22%	1.37%	2.64%	21.03%
Enterprise Value	12,399	11,411	11,044	7,074	7,314	7,488
Last Close Price	30.29	27.66	26.25	21.15	20.39	19.55
PE Ratio	27.97	28.06	37.64	24.20	20.39	14.90
PS Ratio	4.22	4.19	4.10	3.40	3.52	3.17
PB Ratio	2.84	2.71	2.68	2.41	2.35	2.39
P/FCF Ratio	15.05	15.10	25.21	14.18	10.07	9.90
P/OCF Ratio	14.91	14.76	20.29	13.95	9.99	9.81
EV/Sales Ratio	4.52	4.85	5.02	3.92	4.26	4.03
EV/EBITDA Ratio	12.58	13.61	14.74	11.19	11.80	9.73
EV/EBIT Ratio	20.42	21.69	23.87	16.31	17.43	13.78
EV/FCF Ratio	16.91	17.50	30.88	16.37	12.20	12.59
Debt / Equity Ratio	0.36	0.42	0.61	0.34	0.47	0.72
Debt / EBITDA Ratio	1.49	1.78	2.67	1.36	1.91	2.27
Debt / FCF Ratio	1.91	2.32	5.70	2.02	2.01	2.98
Asset Turnover	0.36	0.35	0.35	0.37	0.32	0.33
Inventory Turnover	1.53	1.42	1.38	1.31	1.08	1.34
Quick Ratio	0.66	0.68	0.42	0.51	0.59	0.47
Current Ratio	0.98	1.05	0.64	0.76	1.00	0.78
Return on Equity (ROE)	10.55%	10.46%	7.98%	10.61%	12.34%	17.48%
Return on Assets (ROA)	5.02%	4.87%	4.60%	5.58%	4.89%	5.94%
Return on Capital (ROIC)	6.71%	6.54%	6.46%	8.10%	6.88%	8.17%
Return on Capital Employed (ROCE)	10.00%	9.30%	8.50%	12.00%	9.50%	11.80%
Earnings Yield	3.57%	3.56%	2.66%	4.13%	4.90%	6.71%
FCF Yield	6.64%	6.62%	3.97%	7.05%	9.93%	10.10%
Buyback Yield / Dilution	-2.71%	-6.01%	-9.22%	-0.56%	0.28%	-1.06%

Updated Feb 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.